Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Conditions
Solid Tumors · Non-small Cell Lung Cancer · Renal Cell Carcinoma · Hepatocellular Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
The Seventh Medical Center of the PLA General Hospital, Beijing, Beijing Municipality, China
Beijing Hospital, Beijing, Beijing Municipality, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Zhongshan Hospital,Fudan University(Xiamen Branch), Xiamen, Fujian, China
Dongguan People's Hospital, Dongguan, Guangdong, China
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai, Guangdong, China
Harbin Medical University Cancer Hospital, Haerbin, Heilongjiang, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
The Second Affiliater Hospital of Nanchang University, Nanchang, Jiangxi, China
THE First Hospital of Jilin University, Changchun, Jilin, China
Jilin Cancer Hospital, Changchun, Jilin, China
The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, Shandong, China
First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China
The Cancer Affiliated Hospital of Xinjiang Medical College, Ürümqi, Xinjiang, China
Yunnan Cancer Hospital, Kunming, Yunnan, China
Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Fudan University, Shanghai, China
Contact: Study coordinator (Tianshu Liu)
Study leads
Tianshu Liu
Principal Investigator
Fudan University